Sfoglia per Autore D'AGOSTINO, Mattia
Tracking genetically engineered lymphocytes long-term reveals the dynamics of t cell immunological memory
2015-01-01 Oliveira G.; Ruggiero E.; Stanghellini M.T.L.; Cieri N.; D'Agostino M.; Fronza R.; Lulay C.; Dionisio F.; Mastaglio S.; Greco R.; Peccatori J.; Aiuti A.; Ambrosi A.; Biasco L.; Bondanza A.; Lambiase A.; Traversari C.; Vago L.; Kalle C.V.; Schmidt M.; Bordignon C.; Ciceri F.; Bonini C.
Moving toward a tailored therapy in multiple myeloma
2016-01-01 D'Agostino M.; Palumbo A.
Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors
2017-01-01 Gay, Francesca; D'Agostino, Mattia; Giaccone, Luisa; Genuardi, Mariella; Festuccia, Moreno; Boccadoro, Mario; Bruno, Benedetto
Plasma cell leukemia: update on biology and therapy
2017-01-01 Mina R.; D'Agostino M.; Cerrato C.; Gay F.; Palumbo A.
Novel investigational drugs active as single agents in multiple myeloma
2017-01-01 D'Agostino, Mattia; Salvini, Marco; Palumbo, Antonio; Larocca, Alessandra; Gay, Francesca
Novel Immunotherapies for Multiple Myeloma
2017-01-01 D'Agostino M, Boccadoro M, Smith EL.
Determining treatment intensity in elderly patients with multiple myeloma
2018-01-01 Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S.
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials
2018-01-01 D'Agostino M.; De Paoli L.; Conticello C.; Offidani M.; Ria R.; Petrucci M.T.; Spada S.; Marcatti M.; Catalano L.; Gilestro M.; Guglielmelli T.; Baldini L.; Gamberi B.; Rizzi R.; De Sabbata G.; Di Renzo N.; Patriarca F.; Pezzatti S.; Siniscalchi A.; Ribolla R.; Palumbo A.; Montefusco V.; Nagler A.; Boccadoro M.; Gay F.
Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients
2018-01-01 Larocca, Alessandra*; D'Agostino, Mattia; Boccadoro, Mario
CD38 as an immunotherapeutic target in multiple myeloma
2018-01-01 Bonello F.; D'Agostino M.; Moscvin M.; Cerrato C.; Boccadoro M.; Gay F.
Promises and pitfalls in the use of PD-1/PD-L1 inhibitors in multiple myeloma
2018-01-01 Oliva S.; Troia R.; D'Agostino M.; Boccadoro M.; Gay F.
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma
2018-01-01 Bringhen S.; D'Agostino M.; De Paoli L.; Montefusco V.; Liberati A.M.; Galieni P.; Grammatico S.; Muccio V.E.; Esma F.; De Angelis C.; Musto P.; Ballanti S.; Offidani M.; Petrucci M.T.; Gaidano G.; Corradini P.; Palumbo A.; Sonneveld P.; Boccadoro M.
Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN)
2018-01-01 Larocca, Alessandra*; Dold, Sandra Maria; Zweegman, Sonja; Terpos, Evangelos; Wäsch, Ralph; D’Agostino, Mattia; Scheubeck, Sophia; Goldschmidt, Hartmut; Gay, Francesca; Cavo, Michele; Ludwig, Heinz; Straka, Christian; Bringhen, Sara; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Offidani, Massimo; Dimopoulos, Meletios A.; Einsele, Hermann; Boccadoro, Mario; Sonneveld, Pieter; Engelhardt, Monika
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino
2019-01-01 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial
2019-01-01 Bringhen, Sara; D'Agostino, Mattia; Paris, Laura; Ballanti, Stelvio; Pescosta, Norbert; Spada, Stefano; Pezzatti, Sara; Grasso, Mariella; Rota-Scalabrini, Delia; De Rosa, Luca; Pavone, Vincenzo; Gazzera, Giulia; Aquino, Sara; Poggiu, Marco; Santoro, Armando; Gentile, Massimo; Baldini, Luca; Petrucci, Maria Teresa; Tosi, Patrizia; Marasca, Roberto; Cellini, Claudia; Palumbo, Antonio; Falco, Patrizia; Hájek, Roman; Boccadoro, Mario; Larocca, Alessandra
Anticorpi monoclonali bispecifici nel trattamento del mieloma multiplo
2019-01-01 Mattia D'Agostino; Mario Boccadoro
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies
2019-01-01 D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F.
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
2019-01-01 Bringhen S.; Milan A.; D'Agostino M.; Ferri C.; Wasch R.; Gay F.; Larocca A.; Offidani M.; Zweegman S.; Terpos E.; Goldschmidt H.; Cavo M.; Ludwig H.; Driessen C.; Auner H.W.; Caers J.; Gramatzki M.; Dimopoulos M.A.; Boccadoro M.; Einsele H.; Sonneveld P.; Engelhardt M.
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma
2019-01-01 D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F.
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT
2020-01-01 B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Tracking genetically engineered lymphocytes long-term reveals the dynamics of t cell immunological memory | 2015 | Oliveira G.; Ruggiero E.; Stanghellini M.T.L.; Cieri N.; D'Agostino M.; Fronza R.; Lulay C.; Dionisio F.; Mastaglio S.; Greco R.; Peccatori J.; Aiuti A.; Ambrosi A.; Biasco L.; Bondanza A.; Lambiase A.; Traversari C.; Vago L.; Kalle C.V.; Schmidt M.; Bordignon C.; Ciceri F.; Bonini C. | |
| Moving toward a tailored therapy in multiple myeloma | 2016 | D'Agostino M.; Palumbo A. | |
| Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors | 2017 | Gay, Francesca; D'Agostino, Mattia; Giaccone, Luisa; Genuardi, Mariella; Festuccia, Moreno; Boccadoro, Mario; Bruno, Benedetto | |
| Plasma cell leukemia: update on biology and therapy | 2017 | Mina R.; D'Agostino M.; Cerrato C.; Gay F.; Palumbo A. | |
| Novel investigational drugs active as single agents in multiple myeloma | 2017 | D'Agostino, Mattia; Salvini, Marco; Palumbo, Antonio; Larocca, Alessandra; Gay, Francesca | |
| Novel Immunotherapies for Multiple Myeloma | 2017 | D'Agostino M, Boccadoro M, Smith EL. | |
| Determining treatment intensity in elderly patients with multiple myeloma | 2018 | Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S. | |
| Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials | 2018 | D'Agostino M.; De Paoli L.; Conticello C.; Offidani M.; Ria R.; Petrucci M.T.; Spada S.; Marcatti M.; Catalano L.; Gilestro M.; Guglielmelli T.; Baldini L.; Gamberi B.; Rizzi R.; De Sabbata G.; Di Renzo N.; Patriarca F.; Pezzatti S.; Siniscalchi A.; Ribolla R.; Palumbo A.; Montefusco V.; Nagler A.; Boccadoro M.; Gay F. | |
| Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients | 2018 | Larocca, Alessandra*; D'Agostino, Mattia; Boccadoro, Mario | |
| CD38 as an immunotherapeutic target in multiple myeloma | 2018 | Bonello F.; D'Agostino M.; Moscvin M.; Cerrato C.; Boccadoro M.; Gay F. | |
| Promises and pitfalls in the use of PD-1/PD-L1 inhibitors in multiple myeloma | 2018 | Oliva S.; Troia R.; D'Agostino M.; Boccadoro M.; Gay F. | |
| Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma | 2018 | Bringhen S.; D'Agostino M.; De Paoli L.; Montefusco V.; Liberati A.M.; Galieni P.; Grammatico S.; Muccio V.E.; Esma F.; De Angelis C.; Musto P.; Ballanti S.; Offidani M.; Petrucci M.T.; Gaidano G.; Corradini P.; Palumbo A.; Sonneveld P.; Boccadoro M. | |
| Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN) | 2018 | Larocca, Alessandra*; Dold, Sandra Maria; Zweegman, Sonja; Terpos, Evangelos; Wäsch, Ralph; D’Agostino, Mattia; Scheubeck, Sophia; Goldschmidt, Hartmut; Gay, Francesca; Cavo, Michele; Ludwig, Heinz; Straka, Christian; Bringhen, Sara; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Offidani, Massimo; Dimopoulos, Meletios A.; Einsele, Hermann; Boccadoro, Mario; Sonneveld, Pieter; Engelhardt, Monika | |
| Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro | |
| Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial | 2019 | Bringhen, Sara; D'Agostino, Mattia; Paris, Laura; Ballanti, Stelvio; Pescosta, Norbert; Spada, Stefano; Pezzatti, Sara; Grasso, Mariella; Rota-Scalabrini, Delia; De Rosa, Luca; Pavone, Vincenzo; Gazzera, Giulia; Aquino, Sara; Poggiu, Marco; Santoro, Armando; Gentile, Massimo; Baldini, Luca; Petrucci, Maria Teresa; Tosi, Patrizia; Marasca, Roberto; Cellini, Claudia; Palumbo, Antonio; Falco, Patrizia; Hájek, Roman; Boccadoro, Mario; Larocca, Alessandra | |
| Anticorpi monoclonali bispecifici nel trattamento del mieloma multiplo | 2019 | Mattia D'Agostino; Mario Boccadoro | |
| Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies | 2019 | D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F. | |
| Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension | 2019 | Bringhen S.; Milan A.; D'Agostino M.; Ferri C.; Wasch R.; Gay F.; Larocca A.; Offidani M.; Zweegman S.; Terpos E.; Goldschmidt H.; Cavo M.; Ludwig H.; Driessen C.; Auner H.W.; Caers J.; Gramatzki M.; Dimopoulos M.A.; Boccadoro M.; Einsele H.; Sonneveld P.; Engelhardt M. | |
| Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma | 2019 | D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F. | |
| MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT | 2020 | B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile